Today, the story is very different, and while WTI oil prices have recovered from the lows of the oil rout, both Crescent Point and Baytex continue to trade at or near multi-year lows.
Let’s take a look at the two companies to see if one might be an interesting contrarian pick.
Crescent Point trades for $6.15 per share. That’s pretty much the lowest price in the history of the company. Investors who rode the stock up from its humble beginnings to the glory days are probably looking at the current situation in total disbelief. Crescent Point traded for more than $45 per share in 2014 and paid out a monthly dividend of $0.23. Today, the monthly dividend is $0.03. That’s good for a yield of close to 6%.
Crescent Point has substantial light-oil holdings in Saskatchewan that might be attractive to a larger player looking to add resources at a reasonable price. The current price puts the market capitalization at roughly $3.4 billion and Crescent Point finished Q2 with net debt of $4 billion. The deal would still be hefty at close to $7.5 billion, but a few names in the sector have the balance sheets to pull it off.
The new management team is working hard to reduce debt and streamline the operations, but they might be open to entertaining an offer if it doesn’t look like things can be turned around.
Baytex has fallen even further than Crescent Point. The company traded for more than $48 per share in the summer of 2014 and paid out a monthly dividend of $0.24. A year later, the dividend was gone and management was scrambling to keep the company alive.
Today, despite an improved balance sheet after the merger with Raging River Exploration this year, Baytex remains under pressure. Debt is still high and that is showing up in the stock price. At the time of writing, the shares are trading at $2.70.
The Eagle Ford assets the company bought in a major transaction at the top of the market are getting good WTI prices for their production, but a large part of the Canadian output is sold at Western Canadian Select pricing, which is in the tank right now due to pipeline bottlenecks.
As with Crescent Point, Baytex might become a takeover target.
Is one a better bet right now?
Betting on a big premium on a takeover might not be the best strategy for either of these stocks. If one gets bought, it will likely be close to the trading price.
Regarding a recovery, debt remains a problem and that will only get worse as borrowing costs increase. Neither company has the ability to issue significant shares to pay down debt and revenue would have to ramp up significantly to generate enough cash flow to make a meaningful dent in the debt positions.
At this point, I would look for other opportunities.
When you buy heavily cyclical stocks at low prices… and then hold the shares until the cycle reaches its peak… you can make a very healthy profit.
Every investor knows that. But many struggle to identify the best opportunities.
Except The Motley Fool may have a plan to solve that problem! Our in-house analyst team has poured thousands of hours into their proprietary research – and this is the result.
Our top advisor Iain Butler has just identified his #1 stock to buy in 2018 (and beyond).
The last time this stock went from the low point of its cycle to the peak… shares shot from $12 to $40 inside of 4 years. That’s an 300%-plus return. And if you missed out on that ride, today might just be your second chance.
Fool contributor Andre Walker has no position in any stock mentioned.